Arturo R. Rolla, M.D.

Arturo R. Rolla, M.D. Endocrinologist at Beth Israel Deaconess Medical Center in Boston Massachusetts. He is also Assistant Clinical Professor of Medicine at Harvard Medical School and Tufts University School of Medicine in Boston, Massachusetts and has received awards for excellence in teaching from both institutions. His research focuses on thyroid cancer and other endocrine disorders and he is the author of numerous journal articles and book chapters. Born in Argentina, he graduated Summa Cum Laude from college and medical school at Catholic University of Cordoba. He completed his internship at Mercy Medical Center in Pennsylvania and was chief resident at New England Deaconess Hospital in Boston. He is the owner of the ThyCa listserv, and was integrally involved in the founding of ThyCa.

Matthew D. Ringel, M.D., Endocrinologist, is a thyroid cancer specialist and professor at The Ohio State University Hospital and Research Institute. His research focuses on the molecular mechanisms involved in thyroid cancer invasion and new drug testing for thyroid cancer treatment. The focus of his group has been on clarifying the role of the PI3 kinase/Akt pathway in cancer invasion and metastasis, and on identification of novel endogenous metastasis inhibitor pathways in thyroid cancer. He earned his M.D. degree at Pennsylvania State University, followed by internship and residency at Georgetown University, and a fellowship at Johns Hopkins University.

Scot C. Remick, M.D. is a Medical Oncologist at Maine Medical Center Cancer Institute in Scarborough, Maine. He graduated from New York Medical College and then completed his residency at The Johns Hopkins Hospital and his fellowship at University of Wisconsin. Dr. Remick is American Board Certified in Internal Medicine as well as Medical Oncology. His special interests include AIDS Malignancies, AIDS Research, Developmental Therapeutics, General Oncology, Melanoma, and Thyroid Cancer.

Gregory W. Randolph, M.D., is an Otolaryngologist, at the Massachusetts Eye and Ear Infirmary, where he directs the thyroid clinic. He is also Clinical Associate in the Division of Surgical Oncology at Massachusetts General Hospital, and Associate Professor of Otology and Laryngology at Harvard Medical School. His main clinical interest is thyroid and parathyroid surgery. He earned his medical degree with research honors at Cornell Medical College, New York, and completed postdoctoral training in otolaryngology at the Massachusetts Eye and Ear Infirmary, Boston, Massachusetts. He serves on numerous hospital and national committees, and is the author of numerous articles and book chapters, is editor of medical texts, and has contributed to practice guidelines for thyroid cancer management. He serves on the editorial board of Head and Neck Journal.

Yolanda C. Oertel, M.D. is a Pathologist at the Washington Hospital Center in Washington D.C. She has may years of experience with fine needle aspiration and evaluation of thyroid nodules and has trained many other pathologists in these techniques.

David Myssiorek, M.D., F.A.C.S. is an ENT-Otolaryngologist at Bronxcare Health System, Bronx, NY. He is the author of numerous articles on thyroid cancer surgery and other head and neck surgery. He has conducted numerous surveys of our population in order to learn more from us, with his survey on patients’ voice issues receiving more than 6,000 responses. A graduate of New York University School of Medicine, Dr. Myssiorek did his internship at Lenox Hill Hospital and was Chief Resident at New York University/Bellevue. He is the author of numerous articles on thyroid cancer surgery and other head and neck surgery. At ThyCa conferences Dr. Myssiorek has spoken about general surgical issues and issues related to having additional neck surgeries, as well as on the causes, prevention, and solutions for voice issues.

Jeffrey F. Moley, M.D., Surgeon, was Professor of Surgery, Chief of Endocrine and Oncologic Surgery, and Associate Director of the Siteman Cancer Center at the Washington University School of Medicine, St. Louis, Missouri. He was also Chief of the Surgical Service, at the St. Louis VA Medical Center. Since 2005 he also served on the American Board of Surgery Surgical Oncology Advisory Committee. Dr. Moley was study chair and principal investigator of clinical trials and studies of treatments for metastatic medullary thyroid cancer and differentiated thyroid cancer. A graduate of Harvard University and Columbia University Medical School, he completed post-graduate training at Yale-New Haven Hospital and the National Cancer Institute. The author of dozens of articles as well as books and monographs, Dr. Moley also served on the editorial boards of the American Journal of Clinical Oncology and the Journal of Surgical Oncology.

Mira M. Milas, M.D., F.A.C.S., Endocrine Surgeon, is Professor of Surgery and Chief of Endocrine Surgery at the Banner – University Medical Center in Phoenix, Arizona. Previously, she was an Endocrine Surgeon at the Oregon Health & Science University Knight Cancer Institute in Portland, Oregon. Prior to that she was an Associate Professor at the Cleveland Clinic Lerner College of Medicine. After graduating from Rice University and the University of Texas Medical School at Houston, she completed specialty training at Emory University, Atlanta, Georgia; Emory University Hospitals and School of Medicine and the University of Texas M.D. Anderson Cancer Center in Houston. She has received numerous awards and honors, including being named in the Guide to America’s Top Surgeons 2007 by the Consumers’ Research Council of America. She is extensively involved in research as well as in training other medical professionals. At ThyCa events, her sessions have included thyroid cancer basics for newcomers, thyroid surgery in complex situations including liver metastases, and physician-patient communications.

Bryan McIver, M.B., Ph.D., F.R.C.P., Endocrinologist. He has extensive experience treating patients with thyroid diseases, specifically those faced with aggressive thyroid cancers. He also runs a research lab, working on thyroid cancer genetics and new treatments for patients with thyroid cancer. He has received numerous awards and honors. He graduated Summa Cum Laude in Medical Sciences from the University of Edinburgh in Scotland, received his Ph.D. in Physiology and Biophysics from the University of Vermont; and his M.B. Ch.B. Faculty of Medicine at the University of Edinburgh. He is a member of the American Thyroid Association’s Thyroid Cancer Guidelines Development Group.

Donald Margouleff, M.D., is a Nuclear Medicine Physician at North Shore University Hospital, Manhasset, New York. He is also Clinical Professor at New York University Langone Medical Center. He is a member of the editorial board of the journal Clinical Nuclear Medicine.